Filter
472
Filtered Results: 472
Text search:
booster
Featured
Recommendations
38
New Publications
100
Language
Document type
No document type
212
Guidelines
110
Studies & Reports
56
Fact sheets
28
Manuals
20
Strategic & Response Plan
17
Training Material
10
Situation Updates
7
Brochures
5
Infographics
3
Resource Platforms
2
Videos
2
Countries / Regions
India
31
Global
22
South Africa
16
Germany
10
Western and Central Europe
9
Philippines
8
Namibia
8
Brazil
8
Africa
8
Congo, Democratic Republic of
7
Mozambique
7
Ukraine
7
Senegal
6
Tanzania
6
Argentina
6
Latin America and the Carribbean
6
Zambia
5
Colombia
5
Nigeria
4
Uganda
4
Lesotho
4
East and Southern Africa
4
Ghana
3
Kenya
3
Rwanda
3
Myanmar / Burma
3
Liberia
2
Zimbabwe
2
Nepal
2
Indonesia
2
Benin
2
Botswana
2
Chile
2
West and Central Africa
2
South–East Asia Region
2
Western Pacific Region
2
Venezuela
2
Eastern Europe
2
Burkina Faso
1
Sierra Leone
1
Ethiopia
1
Niger
1
Haiti
1
Syria
1
Bangladesh
1
Switzerland
1
Ecuador
1
Madagascar
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Fiji
1
Russia
1
Moldova
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
169
Clinical Guidelines
78
Women & Child Health
28
Public Health
21
Key Resources
8
Capacity Building
5
Pharmacy & Technologies
2
Toolboxes
COVID-19
103
TB
26
HIV
23
Mental Health
20
Refugee
16
Polio
14
Rapid Response
14
NTDs
13
Pharmacy
12
Conflict
11
Caregiver
10
Ebola
5
Natural Hazards
5
AMR
5
Planetary Health
5
NCDs
5
Disability
2
Cholera
2
Global Health Education
2
Health Financing Toolbox
2
Zika
1
Specific Hazards
1
Social Ethics
1
Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)
recommended
4 August 2021. Currently, Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) is the only COVID-19 vaccine that should be stored and transported at -60ºC to -86ºC ultra-low temperature (ULT) conditions. Prior to use the vaccine can be transferred to -20ºC freezer or +2-8ºC refrigerator at...
This quick guide offers basic information about COVID-19, the Sinovac-CoronaVac COVID-19 vaccine and what to
expect following vaccination: ...
Временное руководство (Первый выпуск 24 мая 2021 г., Обновлено 21 октября 2021 г., Обновлено 15 марта 2022 г.
5 April 2022, Addendum. This policy brief confirms WHO guidance and policy on injection safety in the context of the extraordinary increase in global injections resulting from COVID-19 immunization campaigns. It also calls attention to information on specialized syringes for COVID-19 vaccines and br...
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
MEDBOX Issue Brief no.18.
The MEDBOX team has compiled a new issue brief on the impact of COVID-19 on PLHIV HIV prevention programmes and treatment for this year's World AIDS Day on 1 December 2021.
New funding requirements: CHF 2.8 billion IFRC-wide of which CHF 670 million is channelled through the IFRC Emergency Appeal in support of National Societies
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
Contact tracing and quarantine in the context of COVID-19: interim guidance, 6 July 2022
recommended
Contact tracing for COVID-19 is the process of identifying, assessing, and managing people who have been exposed to someone who has been infected with the SARS-CoV-2 virus, while quarantine is the separation of contacts from other people after exposure to a probable or confirmed case of SARS-CoV-2 i...
Lancet Infect Dis 2022 Published Online April 8, 2022 https://doi.org/10.1016/S1473-3099(22)00225-
The war in Ukraine will have direct and indirect health consequences on conflict affected people, including internally displaced people and refugees. Governments in countries receiving refugees are providing them with access to healthcare. This document aims to provide information to guide individua...
This annual report highlights the work of the WHO from January to June 2021 ( December 2021). The activities featured herein are by no means exhausted but implemented with technical and financial support through WHO in Nigeria; facilitated by its presence at all levels of governance (national, state...
While COVID-19 virus continues to circulate and evolve, new variants are constantly emerging. Most of the current COVID-19 cases are driven by the circulation of the BA.5 subvariant of Omicron. The COVID-19 vaccines are being updated with Omicron variants to provide broader immunity against circulat...
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-...
Dracunculiasis (Guinea worm disease), caused by the parasite Dracunculus medinensis, is traditionally acquired by drinking water containing copepods (water fleas) infected with D. medinensis larvae, but in recent years also appears increasingly to be transmitted by eating fish or other aquatic anima...
The new WHO recommendations for rabies immunization supersede the 2010 WHO position
on pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for rabies. These updated
recommendations are based on new evidence and directed by public health needs that are cost-,
dose- and time-sparing...
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus...
